Trials / Completed
CompletedNCT02360800
Trial Comparing Tisseel as an Adjunct to Traditional Hemostasis After Redo Cardiac Surgery
Randomized Prospective Comparison of Tisseel Or Control to Diminish Blood Loss After Redo Redo Cardiac Surgery: the Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Cardiochirurgia E.H. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Bleeding after redo cardiac surgery is a common, unresolved and consequences-heavy event as per present day. Tisseel (Baxter inc) sprayed on the already hemostased mediastinum jut before closing seems a promising technique to radically diminish bleeding. This study aims to verify this efficacy volume in chest drains) and possibly the consensual blood transfusion lessening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Spray Fibrin Sealant | Baxter Tisseel (Fibrin Sealant) is sprayed in the mediastinum at the end of the operation afetr routine chest hemostasis protocol has been completed, right before closing the chest. |
| PROCEDURE | Traditional Hemostasis and chest Closure Routine | Routine chest hemostasis and closure protocol (gauzes and inspection till satisfactory according to the surgeon) |
Timeline
- Start date
- 2017-02-02
- Primary completion
- 2018-06-03
- Completion
- 2018-09-16
- First posted
- 2015-02-11
- Last updated
- 2018-09-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02360800. Inclusion in this directory is not an endorsement.